CIK 0001453687
RNAC Cartesian Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Dec 30, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company
Signals
Open-market buys and sells at Cartesian Therapeutics, Inc., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 40Moderate | buy | SPRINGER TIMOTHY A director, owner | $965k | 52,189 | +1% | - | |
| 20Weak | sell | Kurtoglu Metin Chief Technology Officer | $345k | 13,664 | -22% | - | |
| 55Moderate | sell 3 | Kurtoglu Metin Chief Technology Officer | $649k | 38,689 | -76% | - | |
| 58Moderate | sell 3 | Jewell Christopher M Chief Scientific Officer | $875k | 52,115 | -84% | - | |
| 59Moderate | sell 3 | Miljkovic Milos Chief Medical Officer | $908k | 55,000 | -103% | - | |
| 60Notable | sell 3 | Kurtoglu Metin Chief Technology Officer | $1.4M | 82,368 | -107% | - | |
| 43Moderate | buy | SPRINGER TIMOTHY A director, owner | $7.4M | 431,940 | +5% | - |
Transactions
The last 61 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 26, 2024 | Singer Michael director | GGift Common Stock | -20,000 | $0.00 | $0 | 70,933 | Dec 30, 2024 |
| Dec 26, 2024 | English Emily SVP, Head of Manufacturing | MOption exercise Common Stock | +7,650 | $3.30 | $25k | 25,923 | Dec 30, 2024 |
| Dec 26, 2024 | English Emily SVP, Head of Manufacturing | MOption exercise Stock Option (Right to Buy)derivative | -7,650 | - | - | 49,369 | Dec 30, 2024 |
| Dec 19, 2024 | SPRINGER TIMOTHY A director, owner | POpen-market purchase Common Stock | +11,303 | $17.39 | $197k | 8,467,009 | Dec 23, 2024 |
| Dec 19, 2024 | SPRINGER TIMOTHY A director, owner | POpen-market purchase Common Stock | +10,529 | $18.35 | $193k | 8,477,538 | Dec 23, 2024 |
| Dec 19, 2024 | SPRINGER TIMOTHY A director, owner | POpen-market purchase Common Stock | +3,376 | $18.93 | $64k | 8,480,914 | Dec 23, 2024 |
| Dec 20, 2024 | SPRINGER TIMOTHY A director, owner | POpen-market purchase Common Stock | +21,800 | $18.94 | $413k | 8,502,714 | Dec 23, 2024 |
| Dec 23, 2024 | SPRINGER TIMOTHY A director, owner | POpen-market purchase Common Stock | +5,181 | $19.00 | $98k | 8,507,895 | Dec 23, 2024 |
| Dec 9, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Common Stock | +10,763 | $1.41 | $15k | 61,796 | Dec 11, 2024 |
| Dec 9, 2024 | Kurtoglu Metin Chief Technology Officer | SOpen-market sale Common Stock | -6,224 | $25.26 | $157k | 55,572 | Dec 11, 2024 |
| Dec 9, 2024 | Kurtoglu Metin Chief Technology Officer | SOpen-market sale Common Stock | -4,539 | $25.83 | $117k | 51,033 | Dec 11, 2024 |
| Dec 10, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Common Stock | +2,901 | $1.41 | $4,090 | 53,934 | Dec 11, 2024 |
| Dec 10, 2024 | Kurtoglu Metin Chief Technology Officer | SOpen-market sale Common Stock | -2,901 | $24.35 | $71k | 51,033 | Dec 11, 2024 |
| Dec 9, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Stock Option (Right to Buy)derivative | -10,763 | - | - | 82,000 | Dec 11, 2024 |
| Dec 10, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Stock Option (Right to Buy)derivative | -2,901 | - | - | 79,099 | Dec 11, 2024 |
| Nov 20, 2024 | Jewell Christopher M Chief Scientific Officer | MOption exercise Common Stock | +14,000 | $3.23 | $45k | 39,940 | Nov 21, 2024 |
| Nov 19, 2024 | Singer Michael director | GGift Common Stock | -28,821 | $0.00 | $0 | 90,933 | Nov 21, 2024 |
| Nov 19, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Common Stock | +200 | $1.41 | $282 | 51,233 | Nov 21, 2024 |
| Nov 20, 2024 | Jewell Christopher M Chief Scientific Officer | MOption exercise Stock Option (Right to Buy)derivative | -14,000 | - | - | 76,432 | Nov 21, 2024 |
| Nov 19, 2024 | Kurtoglu Metin Chief Technology Officer | SOpen-market sale Common Stock | -200 | $19.50 | $3,900 | 51,033 | Nov 21, 2024 |
| Nov 20, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Common Stock | +5,700 | $1.41 | $8,037 | 56,733 | Nov 21, 2024 |
| Nov 20, 2024 | Kurtoglu Metin Chief Technology Officer | SOpen-market sale Common Stock | -5,600 | $17.28 | $97k | 51,133 | Nov 21, 2024 |
| Nov 20, 2024 | Kurtoglu Metin Chief Technology Officer | SOpen-market sale Common Stock | -100 | $18.09 | $1,809 | 51,033 | Nov 21, 2024 |
| Nov 21, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Common Stock | +32,789 | $1.41 | $46k | 83,822 | Nov 21, 2024 |
| Nov 21, 2024 | Kurtoglu Metin Chief Technology Officer | SOpen-market sale Common Stock | -32,789 | $16.67 | $547k | 51,033 | Nov 21, 2024 |
| Nov 19, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Stock Option (Right to Buy)derivative | -200 | - | - | 131,252 | Nov 21, 2024 |
| Nov 20, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Stock Option (Right to Buy)derivative | -5,700 | - | - | 125,552 | Nov 21, 2024 |
| Nov 21, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Stock Option (Right to Buy)derivative | -32,789 | - | - | 92,763 | Nov 21, 2024 |
| Nov 14, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Common Stock | +25,900 | $1.41 | $37k | 76,933 | Nov 18, 2024 |
| Nov 14, 2024 | Miljkovic Milos Chief Medical Officer | MOption exercise Common Stock | +35,000 | $3.23 | $113k | 53,273 | Nov 18, 2024 |
| Nov 14, 2024 | Jewell Christopher M Chief Scientific Officer | MOption exercise Common Stock | +36,050 | $3.23 | $116k | 61,990 | Nov 18, 2024 |
| Nov 14, 2024 | SPRINGER TIMOTHY A director, owner | POpen-market purchase Common Stock | +74,157 | $16.19 | $1.2M | 8,097,923 | Nov 18, 2024 |
| Nov 14, 2024 | Kurtoglu Metin Chief Technology Officer | SOpen-market sale Common Stock | -21,900 | $16.33 | $358k | 55,033 | Nov 18, 2024 |
| Nov 14, 2024 | SPRINGER TIMOTHY A director, owner | POpen-market purchase Common Stock | +22,242 | $16.97 | $377k | 8,120,165 | Nov 18, 2024 |
| Nov 14, 2024 | Miljkovic Milos Chief Medical Officer | SOpen-market sale Common Stock | -35,000 | $16.13 | $565k | 18,273 | Nov 18, 2024 |
| Nov 14, 2024 | Jewell Christopher M Chief Scientific Officer | SOpen-market sale Common Stock | -18,550 | $16.34 | $303k | 43,440 | Nov 18, 2024 |
| Nov 14, 2024 | Kurtoglu Metin Chief Technology Officer | SOpen-market sale Common Stock | -4,000 | $17.06 | $68k | 51,033 | Nov 18, 2024 |
| Nov 14, 2024 | Jewell Christopher M Chief Scientific Officer | SOpen-market sale Common Stock | -17,500 | $17.02 | $298k | 25,940 | Nov 18, 2024 |
| Nov 15, 2024 | Miljkovic Milos Chief Medical Officer | MOption exercise Common Stock | +20,000 | $3.23 | $65k | 38,273 | Nov 18, 2024 |
| Nov 15, 2024 | SPRINGER TIMOTHY A director, owner | POpen-market purchase Common Stock | +277,246 | $17.09 | $4.7M | 8,397,411 | Nov 18, 2024 |
| Nov 15, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Common Stock | +22,068 | $1.41 | $31k | 73,101 | Nov 18, 2024 |
| Nov 15, 2024 | Miljkovic Milos Chief Medical Officer | SOpen-market sale Common Stock | -20,000 | $17.14 | $343k | 18,273 | Nov 18, 2024 |
| Nov 15, 2024 | Jewell Christopher M Chief Scientific Officer | MOption exercise Common Stock | +16,065 | $3.23 | $52k | 42,005 | Nov 18, 2024 |
| Nov 18, 2024 | SPRINGER TIMOTHY A director, owner | POpen-market purchase Common Stock | +38,114 | $17.96 | $684k | 8,435,525 | Nov 18, 2024 |
| Nov 15, 2024 | Kurtoglu Metin Chief Technology Officer | SOpen-market sale Common Stock | -22,068 | $17.20 | $379k | 51,033 | Nov 18, 2024 |
| Nov 15, 2024 | Jewell Christopher M Chief Scientific Officer | SOpen-market sale Common Stock | -16,065 | $17.06 | $274k | 25,940 | Nov 18, 2024 |
| Nov 18, 2024 | SPRINGER TIMOTHY A director, owner | POpen-market purchase Common Stock | +20,181 | $18.42 | $372k | 8,455,706 | Nov 18, 2024 |
| Nov 14, 2024 | Miljkovic Milos Chief Medical Officer | MOption exercise Stock Option (Right to Buy)derivative | -35,000 | - | - | 50,528 | Nov 18, 2024 |
| Nov 15, 2024 | Miljkovic Milos Chief Medical Officer | MOption exercise Stock Option (Right to Buy)derivative | -20,000 | - | - | 30,528 | Nov 18, 2024 |
| Nov 14, 2024 | Jewell Christopher M Chief Scientific Officer | MOption exercise Stock Option (Right to Buy)derivative | -36,050 | - | - | 106,497 | Nov 18, 2024 |
| Nov 18, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Common Stock | +34,400 | $1.41 | $49k | 85,433 | Nov 18, 2024 |
| Nov 15, 2024 | Jewell Christopher M Chief Scientific Officer | MOption exercise Stock Option (Right to Buy)derivative | -16,065 | - | - | 90,432 | Nov 18, 2024 |
| Nov 18, 2024 | Kurtoglu Metin Chief Technology Officer | SOpen-market sale Common Stock | -16,672 | $18.19 | $303k | 68,761 | Nov 18, 2024 |
| Nov 18, 2024 | Kurtoglu Metin Chief Technology Officer | SOpen-market sale Common Stock | -17,728 | $18.58 | $329k | 51,033 | Nov 18, 2024 |
| Nov 14, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Stock Option (Right to Buy)derivative | -25,900 | - | - | 187,920 | Nov 18, 2024 |
| Nov 15, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Stock Option (Right to Buy)derivative | -22,068 | - | - | 165,852 | Nov 18, 2024 |
| Nov 18, 2024 | Kurtoglu Metin Chief Technology Officer | MOption exercise Stock Option (Right to Buy)derivative | -34,400 | - | - | 131,452 | Nov 18, 2024 |
| Oct 11, 2024 | Hoge Elizabeth owner | MOption exercise Common Stockindirect: as trustee | +1,518,373 | - | - | 4,555,260 | Oct 15, 2024 |
| Oct 11, 2024 | Kalayoglu Murat director, owner | MOption exercise Common Stockindirect: by trust | +1,518,373 | - | - | 4,555,260 | Oct 15, 2024 |
| Oct 11, 2024 | Hoge Elizabeth owner | MOption exercise Series A Non-Voting Convertible Preferred Stockderivativeindirect: as trustee | -45,551 | - | - | 56,402 | Oct 15, 2024 |
| Oct 11, 2024 | Kalayoglu Murat director, owner | MOption exercise Series A Non-Voting Convertible Preferred Stockderivativeindirect: by trust | -45,551 | - | - | 56,402 | Oct 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- English EmilySVP, Head of Manufacturing
- Hoge Elizabethowner
- Jewell Christopher MChief Scientific Officer
- Kalayoglu Muratdirector, owner
- Kurtoglu MetinChief Technology Officer
- Miljkovic MilosChief Medical Officer
- SPRINGER TIMOTHY Adirector, owner
- Singer Michaeldirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.